| Identification | More | [Name]
Rosiglitazone hydrochloride | [CAS]
302543-62-0 | [Synonyms]
ROSIGLITAZONE HYDROCHLORIDE 99%
5-[4-[2-[N-Methyl-N-(pyridinyl) amino]ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride
Rosiglitazone hydrochloride | [EINECS(EC#)]
1308068-626-2 | [Molecular Formula]
C18H19N3O3S.HCl | [MDL Number]
MFCD04112701 | [Molecular Weight]
393.89 | [MOL File]
302543-62-0.mol |
| Hazard Information | Back Directory | [Chemical Properties]
Rosiglitazone is a hypoglycemic drug developed by GS, and the revalent compounds are disclosed in European Patent EP 306228. | [Uses]
Rosiglitazone hydrochloride has better stability than rosiglitazone maleate, and is very suitable for application in the manufacture of common pharmaceutical preparations. It is a thiazolidinedione antidiabetic drug, which can effectively control blood sugar by improving insulin sensitivity. | [Biological Activity]
rosiglitazone is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the ppar receptors in fat cells. | [target]
|
|
|